The recovery of spleen cells infected with Rauscher leukemia virus (RLV) and grown in Millipore diffusion chambers, the development of RLV-induced splenomegaly, and the cumulative mortality from a transplanted ascites plasma-cell tumor were all suppressed in young adult BALB/c male mice previously primed at 3-weekly intervals with x-irradiated, syngeneic Numerous reports have suggested that fetal cells have antigens that cross-react with specific transplantation antigens in tumor cells (1-6). Although the overall concept is unclear, it is proposed that, upon neoplastic transformation, cells of mature individuals express activity of gene groups that were functional during fetal life but were later repressed. Thus it is possible that during the process of oncogenesis there is a derepression of fetal genes, resulting in the de novo synthesis of antigenic substances detectable as transplantation antigens of tumors. In humans, three classes of embryonal antigens of tumor cells have been described. Gold and Freeman (7) found that fetal gut, liver, and pancreas possess antigen that cross-reacts with specific tumor antigen of the digestive system. These components were named "carcinoembryonic" antigens of the human colon tumor. Abelev (8) mid-gestation, x-irradiated, syngeneic or xenogenic mouse fetus possessed cytostatic antibody to SV40 tumors and were immune to SV40 tumor transplant. Subsequent studies showed that unirradiated fetal cells were poorly immunogenic, differentiated rapidly, and produced embryomas at the site of inoculation (11). Cytotoxic alloantibody against mouse ova was also active against SV40 tumor cells, and immunofluorescence studies revealed that methylcholanthrene-induced